(Circulation. 1995;91:494-504.)
© 1995 American Heart Association, Inc.
Articles |
From the Departments of Pediatrics and Molecular Biology and Pharmacology (A.W.S.), Washington University School of Medicine, St Louis, Mo.
Correspondence to Arnold W. Strauss, MD, Division of Pediatric Cardiology, Department of Pediatrics, Box 8116, St Louis Children's Hospital, One Children's Place, St Louis, MO 63110.
Background This review discusses the incidence and importance of congenital heart disease (CHD), the reasons that investigation of causative mechanisms for human CHD has been slow, and the limitations of the multifactorial theory for the etiology of CHD.
Methods and Results The molecular defects underlying three vasculopathiesMarfan's syndrome (fibrillin), supravalvar aortic stenosis, and Williams' syndrome (elastin)and hereditary telangiectasia are presented to emphasize the role of microfibrils and extracellular matrix in the pathophysiology of these vascular defects. Animal models of CHD, including situs inversus, canine conotruncal malformations, and chick neural crest ablation, are examined to emphasize how such studies relate to human CHD, especially by pointing to single-gene defects for conotruncal malformations, candidate loci for situs inversus, and phenotypic variability caused by neural crest lesions. The crucial role of cardiac transcription factors in heart morphogenesis is emphasized by review of gene knockout studies of these factors, which cause fetal death secondary to heart maldevelopment. Several lines of evidence demonstrating genetic etiologies of human CHD are also presented, including the mapping of familial atrial septal defects, to prove that one anatomic type of CHD may be due to single-gene defects at different loci. Review of atrioventricular canal, both secondary to trisomy 21 and as an autosomal-dominant familial defect, reiterates this conclusion. The evidence that monosomy on chromosome 22 causes multiple types of CHD, including aortic arch and conotruncal defects as part of the CATCH-22 syndrome, is presented, with results supporting the idea that deletions at this site alone may cause 5% of surgically treated CHD.
Conclusions We conclude that (1) human CHD is frequently due to single-gene defects and that even sporadic defects may arise from a single-gene abnormality; (2) a common genetic defect may cause several apparently different forms of CHD; (3) elucidation of the genetic basis of CHD provides clues to normal cardiovascular developmental biology; (4) the same cardiac malformation can be caused by mutant genes at different loci; and (5) interactions of clinical investigators (cardiologists and cardiothoracic surgeons) with basic scientists should allow more rapid progress in defining the genetic basis of CHD.
Key Words: molecular biology heart diseases genes
This article has been cited by other articles:
![]() |
M. N. Benzadon, J. P. Costabel, A. A. de Lima, F. Botto, M. E. Aris Cancela, G. Vaccarino, M. Trivi, and D. Navia Aortic valve replacement in a patient with Osler-Rendu-Weber disease. Ann. Thorac. Surg., July 1, 2009; 88(1): e3 - e4. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Bijlsma, M. P. Peppelenbosch, and C. A. Spek Hedgehog Morphogen in Cardiovascular Disease Circulation, October 31, 2006; 114(18): 1985 - 1991. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Caputo, G. Capozzi, M. G. Russo, T. Esposito, L. Martina, D. Cardaropoli, C. Ricci, P. Argiento, G. Pacileo, and R. Calabro Familial recurrence of congenital heart disease in patients with ostium secundum atrial septal defect Eur. Heart J., October 2, 2005; 26(20): 2179 - 2184. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Brown, S. N. Martz, O. Binder, S. C. Goetz, B. M. J. Price, J. C. Smith, and F. L. Conlon Tbx5 and Tbx20 act synergistically to control vertebrate heart morphogenesis Development, February 1, 2005; 132(3): 553 - 563. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.A.V. Jones, M.H. Baron, S.E. Fraser, and M.E. Dickinson Measuring hemodynamic changes during mammalian development Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1561 - H1569. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. I. Koppel, C. M. Druschel, T. Carter, B. E. Goldberg, P. N. Mehta, R. Talwar, and F. Z. Bierman Effectiveness of Pulse Oximetry Screening for Congenital Heart Disease in Asymptomatic Newborns Pediatrics, March 1, 2003; 111(3): 451 - 455. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Feng, W. Song, X. Lu, J. A. Hamilton, M. Lei, T. Peng, and S.-P. Yee Development of Heart Failure and Congenital Septal Defects in Mice Lacking Endothelial Nitric Oxide Synthase Circulation, August 13, 2002; 106(7): 873 - 879. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Ross and T. K. Borg Integrins and the Myocardium Circ. Res., June 8, 2001; 88(11): 1112 - 1119. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Sze and K. E. Yutzey The Molecular Genetic Revolution in Congenital Heart Disease Am. J. Roentgenol., March 1, 2001; 176(3): 575 - 581. [Full Text] [PDF] |
||||
![]() |
B. Modan, L. Keinan, T. Blumstein, and S. Sadetzki Cancer following cardiac catheterization in childhood Int. J. Epidemiol., June 1, 2000; 29(3): 424 - 428. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Tennstedt, R Chaoui, H Korner, and M Dietel Spectrum of congenital heart defects and extracardiac malformations associated with chromosomal abnormalities: results of a seven year necropsy study Heart, July 1, 1999; 82(1): 34 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Farrell, H. Stadt, K. T. Wallis, P. Scambler, R. L. Hixon, R. Wolfe, L. Leatherbury, and M. L. Kirby HIRA, a DiGeorge Syndrome Candidate Gene, Is Required for Cardiac Outflow Tract Septation Circ. Res., February 5, 1999; 84(2): 127 - 135. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Chazaud, P Chambon, and P Dolle Retinoic acid is required in the mouse embryo for left-right asymmetry determination and heart morphogenesis Development, January 6, 1999; 126(12): 2589 - 2596. [Abstract] [PDF] |
||||
![]() |
M Chessa, G Butera, P Bonhoeffer, L Iserin, J Kachaner, S Lyonnet, A Munnich, D Sidi, and D Bonnet Relation of genotype 22q11 deletion to phenotype of pulmonary vessels in tetralogy of Fallot and pulmonary atresia-ventricular septal defect Heart, February 1, 1998; 79(2): 186 - 190. [Abstract] [Full Text] |
||||
![]() |
Y. J. Woo, G. P. Raju, J. L. Swain, M. E. Richmond, T. J. Gardner, and R. J. Balice-Gordon In Utero Cardiac Gene Transfer via Intraplacental Delivery of Recombinant Adenovirus Circulation, November 18, 1997; 96(10): 3561 - 3569. [Abstract] [Full Text] |
||||
![]() |
Y Takihara, D Tomotsune, M Shirai, Y Katoh-Fukui, K Nishii, M. Motaleb, M Nomura, R Tsuchiya, Y Fujita, Y Shibata, et al. Targeted disruption of the mouse homologue of the Drosophila polyhomeotic gene leads to altered anteroposterior patterning and neural crest defects Development, January 10, 1997; 124(19): 3673 - 3682. [Abstract] [PDF] |
||||
![]() |
L. Sanford, I Ormsby, A. Gittenberger-de Groot, H Sariola, R Friedman, G. Boivin, E. Cardell, and T Doetschman TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes Development, January 7, 1997; 124(13): 2659 - 2670. [Abstract] [PDF] |
||||
![]() |
M. Fishman and K. Chien Fashioning the vertebrate heart: earliest embryonic decisions Development, January 6, 1997; 124(11): 2099 - 2117. [Abstract] [PDF] |
||||
![]() |
A. T. Yilmaz, M. Arslan, E. Ozal, H. Byngol, H. Tatar, and O. Y. Ozturk Coronary Artery Aneurysm Associated With Adult Supravalvular Aortic Stenosis Ann. Thorac. Surg., October 1, 1996; 62(4): 1205 - 1207. [Abstract] [Full Text] |
||||
![]() |
D. Srivastava, P. Cserjesi, and E. N. Olson A Subclass of bHLH Proteins Required for Cardiac Morphogenesis Science, December 22, 1995; 270(5244): 1995 - 1999. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |